These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 7517800

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.
    Shahid M, Nicholson CD.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):698-705. PubMed ID: 1710786
    [Abstract] [Full Text] [Related]

  • 3. Developmental changes in modulation of contractility of rabbit hearts.
    Akita T, Kumar R, Joyner RW.
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):240-51. PubMed ID: 7538615
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interaction of phosphodiesterase inhibitor and isoproterenol in human and guinea-pig ventricular tissues and myocytes.
    Cheng PY, Lin CI, Lee FY, Chen YC, Lu HH.
    Chin J Physiol; 1995 Feb; 38(3):185-91. PubMed ID: 8846728
    [Abstract] [Full Text] [Related]

  • 7. Developmental changes in the beta-adrenergic modulation of calcium currents in rabbit ventricular cells.
    Osaka T, Joyner RW.
    Circ Res; 1992 Jan; 70(1):104-15. PubMed ID: 1309313
    [Abstract] [Full Text] [Related]

  • 8. Contribution of phosphodiesterase isozymes to the regulation of the L-type calcium current in human cardiac myocytes.
    Kajimoto K, Hagiwara N, Kasanuki H, Hosoda S.
    Br J Pharmacol; 1997 Aug; 121(8):1549-56. PubMed ID: 9283687
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
    Park WK, Chang CH, Chae JE, Kim MH, Cho YL, Ahn DS.
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    Hatzelmann A, Tenor H, Schudt C.
    Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.
    Wynne DG, Poole-Wilson PA, Harding SE.
    Br J Pharmacol; 1993 Aug; 109(4):1071-8. PubMed ID: 7691363
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of cGMP on L-type calcium current of adult and newborn rabbit ventricular cells.
    Kumar R, Namiki T, Joyner RW.
    Cardiovasc Res; 1997 Mar; 33(3):573-82. PubMed ID: 9093527
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells.
    Pan X, Arauz E, Krzanowski JJ, Fitzpatrick DF, Polson JB.
    Biochem Pharmacol; 1994 Aug 17; 48(4):827-35. PubMed ID: 7521642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.